The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine-Reference-Cited by-同舟云学术

The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine

Published:2009-08 Issue:2 Volume:68 Page:238-242
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Gjerden Pål,Slørdal Lars,Bramness Jørgen G.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2009.03446.x/fullpdf

Reference15 articles.

1. The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study;Gjerden;Br J Clin Pharmacol,2009

2. Fatalities caused by anticholinergic antiparkinsonian drugs: a retrospective study of a series of Norwegian cases;Gjerden;Tidsskr Nor Laegeforen,1998

3. Fatality index of drugs used in the treatment of psychotic illnesses;Buckley;Br J Psychiatry,1998

4. Effect of warnings in a medical journal on the use of orphenadrine;Gjerden;J Eval Clin Pract,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study;Clinical Toxicology;2024-03-03

2. Insights into the reactivity properties, docking, DFT and MD simulations of orphenadrinium dihydrogen citrate in different solvents;Journal of Molecular Liquids;2022-12

3. Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics;Frontiers in Psychiatry;2022-05-17

4. Dyskinesia induced by orphenadrine in fixed combination with diclofenac in two patients with advanced Parkinson's disease;Klinická farmakologie a farmacie;2021-07-06

5. Interaction of N-succinyl diaminopimelate desuccinylase with orphenadrine and disulfiram;Journal of Molecular Structure;2020-12